Document is current
Any future updates will be listed below
-
Authors
McGill, Janet B. https://orcid.org/0000-0002-6228-6521
Johnson, Mariko
Hurst, Stacy
Cade, William T.
Yarasheski, Kevin E.
Ostlund, Richard E.
Schechtman, Kenneth B.
Razani, Babak
Kastan, Michael B.
McClain, Donald A.
de las Fuentes, Lisa
Davila-Roman, Victor G.
Ory, Daniel S.
Wickline, Samuel A.
Semenkovich, Clay F.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00455325 at ClinicalTrials.govnct00455403 at ClinicalTrials.govDocuments that mention this clinical trial
Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness
https://doi.org/10.1186/s13098-019-0456-4
Documents that mention this clinical trial
Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness
https://doi.org/10.1186/s13098-019-0456-4
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL083762, DK020579, DK076729)
- License Information
-
More Information
Article History
Received: 5 April 2019
Accepted: 20 July 2019
First Online: 29 July 2019
Ethics approval and consent to participate
: Ethics approval was granted by the Washington University Human Research Protection Office, Washington University in St. Louis, St. Louis, Missouri. All patients provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
